Newer anticoagulants, known as non-vitamin K oral anticoagulants (NOACs), are recommended over the traditional warfarin to prevent stroke in people with atrial fibrillation (AFib). Weight loss is recommended for overweight or obese people with AFib.
Updated treatment guidelines for atrial fibrillation recommend a new class of blood thinners to help prevent stroke
